|
| 35977699 | Circulating Endothelial Cells are Associated with Thromboembolic Events in Patients with Antiphospholipid Antibodies. | Thromb Haemost | 2023 |
| 37706025 | Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial. | Front Med (Lausanne) | 2023 |
| 37574520 | Soluble TREM-1 plasma concentration predicts poor outcome in COVID-19 patients. | Intensive Care Med Exp | 2023 |
| 37350989 | Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trial. | EClinicalMedicine | 2023 |
| 37269870 | Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial. | Lancet Respir Med | 2023 |
| 36810101 | Fluid balance control in critically ill patients: results from POINCARE-2 stepped wedge cluster-randomized trial. | Crit Care | 2023 |
| 36687437 | Clinical outcomes and characteristics of critically ill patients with influenza- and COVID-19-induced ARDS: A retrospective, matched cohort study. | Front Med (Lausanne) | 2023 |
| 36942789 | Hydrocortisone in Severe Community-Acquired Pneumonia. | N Engl J Med | 2023 |
| 36699032 | Triggering receptor expressed on myeloid cells-1 deletion in mice attenuates high-fat diet-induced obesity. | Front Endocrinol (Lausanne) | 2023 |
| 35360736 | Comparison of SARS-CoV-2 Variants of Concern Alpha (B.1.1.7) vs. Beta (B.1.351) in Critically Ill Patients: A Multicenter Cohort Study. | Front Med (Lausanne) | 2022 |
| 33420354 | Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis. | Cell Mol Immunol | 2021 |
| 35844707 | Lactic acidosis and hypoglycemia as markers of disease progression of multiple myeloma: A case report. | EJHaem | 2021 |
| 35004712 | Positive End-Expiratory Pressure Setting in COVID-19-Related Acute Respiratory Distress Syndrome: Comparison Between Electrical Impedance Tomography, PEEP/FiO<sub>2</sub> Tables, and Transpulmonary Pressure. | Front Med (Lausanne) | 2021 |
| 34534607 | Plasma and genetic determinants of soluble TREM-1 and major adverse cardiovascular events in a prospective cohort of acute myocardial infarction patients. Results from the FAST-MI 2010 study. | Int J Cardiol | 2021 |
| 34233965 | Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial. | BMJ Open | 2021 |
| 34089117 | Mental health and stress among ICU healthcare professionals in France according to intensity of the COVID-19 epidemic. | Ann Intensive Care | 2021 |
| 34195785 | Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19. | Biosci Rep | 2021 |
| 34112941 | Obesity and mortality in critically ill COVID-19 patients with respiratory failure. | Int J Obes (Lond) | 2021 |
| 34282296 | sTREM-1 is a specific biomarker of TREM-1 pathway activation. | Cell Mol Immunol | 2021 |
| 32468087 | Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial. | Intensive Care Med | 2020 |
| 32056017 | Feasibility, reproducibility and diagnostic usefulness of right ventricular strain by 2-dimensional speckle-tracking echocardiography in ARDS patients: the ARD strain study. | Ann Intensive Care | 2020 |
| 32041533 | Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report. | BMC Infect Dis | 2020 |
| 31767118 | Emergence of antibodies endowed with proteolytic activity against High-mobility group box 1 protein (HMGB1) in patients surviving septic shock. | Cell Immunol | 2020 |
| 31680426 | Inhibition of triggering receptor expressed on myeloid cells-1 impairs thrombin generation. | J Thromb Haemost | 2020 |
| 31733681 | Soluble Triggering Receptor Expressed on Myeloid Cells-1: Diagnosis or Prognosis? | Crit Care Clin | 2020 |
| 32808462 | Mesenchymal stromal cells for sepsis and septic shock: Lessons for treatment of COVID-19. | Stem Cells Transl Med | 2020 |
| 32602969 | Comparison of sTREM-1 and associated periodontal and bacterial factors before/after periodontal therapy, and impact of psychosocial factors. | J Clin Periodontol | 2020 |
| 32623470 | Long-term ACE Inhibitor/ARB Use Is Associated With Severe Renal Dysfunction and Acute Kidney Injury in Patients With Severe COVID-19: Results From a Referral Center Cohort in the Northeast of France. | Clin Infect Dis | 2020 |
| 32984786 | The spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: A longitudinal cohort and time-series design study. | EClinicalMedicine | 2020 |
| 29568119 | TREM-1 multimerization is essential for its activation on monocytes and neutrophils. | Cell Mol Immunol | 2019 |
| 30089551 | Endothelial-driven increase in plasma thrombin generation characterising a new hypercoagulable phenotype in acute heart failure. | Int J Cardiol | 2019 |
| 31632399 | Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation. | Front Immunol | 2019 |
| 31248453 | Bone marrow vs Wharton's jelly mesenchymal stem cells in experimental sepsis: a comparative study. | Stem Cell Res Ther | 2019 |
| 30871305 | Automated measurement of neutrophil CD64 expression for diagnosing sepsis in critically ill patients. | Minerva Anestesiol | 2019 |
| 30882551 | An enlarged left adrenal gland is an indirect sign of infection on 18F-FDG PET/CT. | Nucl Med Commun | 2019 |
| 28726362 | Early hypertension after vasopressor weaning during septic shock: associated factors and prognostic significance. | Minerva Anestesiol | 2018 |
| 29885068 | A first-in-man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM-1 receptor inhibition. | Br J Clin Pharmacol | 2018 |
| 30091119 | Clinical-grade mesenchymal stem cells derived from umbilical cord improve septic shock in pigs. | Intensive Care Med Exp | 2018 |
| 30392084 | Brief summary of French guidelines for the prevention, diagnosis and treatment of hospital-acquired pneumonia in ICU. | Ann Intensive Care | 2018 |
| 29779263 | Effects of Porphyromonas gingivalis LPS and LR12 peptide on TREM-1 expression by monocytes. | J Clin Periodontol | 2018 |
| 29361046 | Targeted endothelial gene deletion of triggering receptor expressed on myeloid cells-1 protects mice during septic shock. | Cardiovasc Res | 2018 |
| 29721786 | Data-driving methods: More than merely trendy buzzwords? | Ann Intensive Care | 2018 |
| 29155054 | Hospital-acquired pneumonia in ICU. | Anaesth Crit Care Pain Med | 2018 |
| 28961797 | TREM-1 Inhibition Restores Impaired Autophagy Activity and Reduces Colitis in Mice. | J Crohns Colitis | 2018 |
| 29138897 | Correction to: Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study. | Intensive Care Med | 2018 |
| 27790740 | LR12-peptide quantitation in whole blood by RP-HPLC and intrinsic fluorescence detection: Validation and pharmacokinetic study. | Biomed Chromatogr | 2017 |
| 28232200 | One-week in vivo sustained release of a peptide formulated into in situ forming implants. | Int J Pharm | 2017 |
| 28245991 | TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives. | Pharmacol Ther | 2017 |
| 29116572 | Admission of tetanus patients to the ICU: a retrospective multicentre study. | Ann Intensive Care | 2017 |
| 28837205 | Triggering Receptor Expressed on Myeloid cells-1: a new player in platelet aggregation. | Thromb Haemost | 2017 |